enGene (ENGN) earnings
In the quarter ended July 2026, enGene had revenue of —, and diluted EPS of -0.47.
On September 8, 2026 it reported EPS of 0.47 against an estimate of -0.44 (beat).
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Last | Tue Sep 8, 2026 | — | -0.44 | 0.47 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from enGene's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | — | — | -0.47 | — | — | 2026-09-08 |
| Apr 30, 2026 | — | — | -0.43 | — | — | 2026-06-15 |
| Jan 31, 2026 | — | — | 0.44 | -8.3% | — | 2026-03-09 |
| Oct 31, 2025 | — | — | — | — | — | 2025-12-22 |
| Jul 31, 2025 | — | — | -0.57 | -278.1% | — | 2025-09-11 |
| Apr 30, 2025 | — | — | -0.51 | -234.2% | — | 2025-06-12 |
| Jan 31, 2025 | — | — | 0.48 | +4.3% | — | 2025-03-10 |
| Oct 31, 2024 | — | — | — | — | — | 2024-12-19 |
| Jul 31, 2024 | — | — | 0.32 | -96.3% | — | 2024-09-10 |
| Apr 30, 2024 | — | — | 0.38 | -95.9% | — | 2024-06-14 |
| Jan 31, 2024 | — | — | 0.46 | -96.5% | — | 2024-03-11 |
| Oct 31, 2023 | — | — | — | — | — | 2024-01-29 |
Questions
How did enGene do last quarter?
In the quarter ended July 2026, enGene had revenue of —, and diluted EPS of -0.47.
From enGene's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.